Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Agilent Technologies Price Performance
A Stock opened at $139.97 on Friday. The stock has a market capitalization of $41.81 billion, a price-to-earnings ratio of 31.88, a price-to-earnings-growth ratio of 2.72 and a beta of 1.06. The company has a quick ratio of 1.49, a current ratio of 2.01 and a debt-to-equity ratio of 0.53. Agilent Technologies has a 52-week low of $112.52 and a 52-week high of $179.57. The stock's fifty day simple moving average is $123.94 and its 200-day simple moving average is $127.69.
Agilent Technologies (NYSE:A - Get Rating) last issued its quarterly earnings results on Tuesday, August 16th. The medical research company reported $1.34 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.20 by $0.14. The firm had revenue of $1.72 billion for the quarter, compared to analyst estimates of $1.64 billion. Agilent Technologies had a return on equity of 28.29% and a net margin of 19.94%. The firm's quarterly revenue was up 8.3% on a year-over-year basis. During the same period last year, the company earned $1.10 EPS. Equities research analysts expect that Agilent Technologies will post 4.88 EPS for the current year.
Wall Street Analysts Forecast Growth
A has been the subject of several research analyst reports. Bank of America raised their price objective on Agilent Technologies from $148.00 to $155.00 and gave the company a "buy" rating in a research note on Wednesday. StockNews.com downgraded Agilent Technologies from a "strong-buy" rating to a "buy" rating in a research note on Thursday. Robert W. Baird increased their price objective on shares of Agilent Technologies from $155.00 to $160.00 and gave the company an "outperform" rating in a research note on Wednesday. Wells Fargo & Company lifted their target price on shares of Agilent Technologies from $130.00 to $135.00 and gave the stock an "equal weight" rating in a research report on Wednesday. Finally, Citigroup increased their price target on shares of Agilent Technologies from $140.00 to $145.00 and gave the company a "neutral" rating in a research report on Wednesday. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $150.18.
Insider Activity at Agilent Technologies
In other news, VP Padraig Mcdonnell sold 1,000 shares of the business's stock in a transaction on Thursday, June 30th. The shares were sold at an average price of $118.62, for a total transaction of $118,620.00. Following the completion of the sale, the vice president now directly owns 17,826 shares of the company's stock, valued at approximately $2,114,520.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, VP Padraig Mcdonnell sold 1,000 shares of the business's stock in a transaction dated Thursday, June 30th. The stock was sold at an average price of $118.62, for a total transaction of $118,620.00. Following the completion of the sale, the vice president now owns 17,826 shares in the company, valued at approximately $2,114,520.12. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Jacob Thaysen sold 5,879 shares of the firm's stock in a transaction that occurred on Thursday, June 2nd. The shares were sold at an average price of $127.43, for a total transaction of $749,160.97. Following the completion of the transaction, the vice president now owns 88,737 shares in the company, valued at approximately $11,307,755.91. The disclosure for this sale can be found here.
